Find clinical trials for COVID-19 in Atlanta, GA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
COVID-19 trials near Atlanta, GA, USA:
condition that puts them at increased risk for severe outcomes of COVID-19 and who have been previously vaccinated with a COVID...
Phase 4
Atlanta, Georgia, United States and 19 other locations
This early-stage study will look at a new mRNA vaccine that combines defenses against both seasonal flu and COVID-19 in terms of it-...
Phase 1
Stockbridge, Georgia, United States and 11 other locations
The purpose of this study is to investigate the immunogenicity and safety of mRNA COVID-19 variant-containing vaccine formulations ...
Phase 4
Atlanta, Georgia, United States and 5 other locations
vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19).In order to represent a more recently circulating SAR...
Phase 2
Lilburn, Georgia, United States and 144 other locations
The purpose of this study is to learn about the safety and effects of updated COVID-19 vaccines (called BNT162b2) in participants 5-...
Phase 3
Atlanta, Georgia, United States of America and 13 other locations
Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most oft-...
Phase 3
Union City, Georgia, United States and 227 other locations
The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do n...
Phase 3
Decatur, Georgia, United States and 262 other locations
study treatment works in the study) of the study medicine (called nirmatrelvir/ritonavir) for potential treatment of coronavirus disease 2019 (COVID...
Phase 3
Atlanta, Georgia, United States and 74 other locations
The purpose of this study is to learn about the safety and effects of the vaccine (called COMIRNATY) for the potential prevention of COVID-19...
Phase 4
Atlanta, Georgia, United States and 17 other locations
the efficacy and safety of mRNA-1283 and mRNA-1273 (variant formulations) in adults 50 to 64 years of age without high risk factors for severe COVID...
Phase 4
Decatur, Georgia, United States and 149 other locations
Clinical trials
Research sites
Resources
Legal